Literature DB >> 36245680

Natural history and management of refractory autoimmune hepatitis.

Bridget Whitehead1, Alyssa Kriegermeier1.   

Abstract

Content available: Author Interview and Audio Recording.
© 2022 American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 36245680      PMCID： PMC9549313          DOI： 10.1002/cld.1231

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  22 in total

Review 1.  The Contribution of B Cells in Autoimmune Liver Diseases.

Authors:  Sarah A Taylor; David N Assis; Cara L Mack
Journal:  Semin Liver Dis       Date:  2019-06-21       Impact factor: 6.115

2.  Budesonide in Autoimmune Hepatitis: The Right Drug at the Right Time for the Right Patient.

Authors:  Michael P Manns; Elmar Jaeckel; Richard Taubert
Journal:  Clin Gastroenterol Hepatol       Date:  2017-11-08       Impact factor: 11.382

Review 3.  Management of Difficult Cases of Autoimmune Hepatitis.

Authors:  Craig Lammert; Veronica M Loy; Kiyoko Oshima; Samer Gawrieh
Journal:  Curr Gastroenterol Rep       Date:  2016-02

4.  Successful treatment of refractory autoimmune hepatitis with rituximab.

Authors:  Daniel D'Agostino; Alejandro Costaguta; Fernando Álvarez
Journal:  Pediatrics       Date:  2013-07-01       Impact factor: 7.124

5.  Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement.

Authors:  Giorgina Mieli-Vergani; Diego Vergani; Ulrich Baumann; Piotr Czubkowski; Dominique Debray; Antal Dezsofi; Björn Fischler; Girish Gupte; Loreto Hierro; Giuseppe Indolfi; Jörg Jahnel; Françoise Smets; Henkjan J Verkade; Nedim Hadžić
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-02       Impact factor: 2.839

Review 6.  Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis.

Authors:  Andréanne N Zizzo; Pamela L Valentino; Prakesh S Shah; Binita M Kamath
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-07       Impact factor: 2.839

Review 7.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

8.  Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis.

Authors:  Christina Weiler-Normann; Christoph Schramm; Alexander Quaas; Christiane Wiegard; Claudia Glaubke; Nadine Pannicke; Sina Möller; Ansgar W Lohse
Journal:  J Hepatol       Date:  2012-11-21       Impact factor: 25.083

9.  Use of sirolimus in the treatment of refractory autoimmune hepatitis.

Authors:  Hemant Chatrath; Larissa Allen; Thomas D Boyer
Journal:  Am J Med       Date:  2014-06-27       Impact factor: 4.965

10.  The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review.

Authors:  Zhaoyue Wang; Li Sheng; Yue Yang; Fan Yang; Xiao Xiao; Jing Hua; Canjie Guo; Yiran Wei; Ruqi Tang; Qi Miao; Jun Zhang; Yanmei Li; Jingyuan Fang; Dekai Qiu; Edward L Krawitt; Christopher L Bowlus; M Eric Gershwin; Qixia Wang; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.